National Abortion Federation Meeting

Gynuity staff and colleagues presented a range of presentations during this annual conference.

Simplifying medical abortion in the United States
Bracken, H.

What can adverse event reporting to the FDA tell us about the safety of mifepristone-misoprostol medical abortion?
Shannon, C.

Exploring optimal non-vaginal dosages and routes of misoprostol administration in mifepristone medical abortion
Chong, E.

Panel – Self-induced abortion using misoprostol alone: Legal, medical and policy implications
Peña, M. et al.

Panel – Serious infection and medication abortion: Comparing the rate of serious infection with mifepristone and vaginal misoprostol versus buccal and oral misoprostol with and without routine antibiotic coverage
Winikoff, B. et al.